N495
N495 releases at Optima Chemical Group LLC fell from 279k lb to 0 lb (100% lower) between 2023 and 2024.
TRI facility · TRI 2024 reporting year
Optima Chemical Group LLC
Total reported releases 2k lb more than halved year over year (-99%). Total releases concentrations have more than doubled since 2010.
200 WILLACOOCHEE HWY, Douglas, Georgia · 325199 · Chemicals · operated by Optima Chemical Group LLC
Anomaly engine
Notable Signals
Chemicals reported · most recent year
What This Facility Releases
Methanol
Methanol concentrations have more than doubled since 2010.
Cyclohexane
Cyclohexane concentrations are up 11% since 2023.
n-Hexane
n-Hexane concentrations have more than doubled since 2010.
Toluene
Toluene concentrations have more than doubled since 2010.
tert-Butyl alcohol
tert-Butyl alcohol volumes here are too small to anchor a multi-year trend; YoY movement is still shown above.
Styrene
Styrene concentrations are up 29% since 2023.
1,2-Dichloroethane
1,2-Dichloroethane concentrations are up 80% since 2023.
N,N-Dimethylformamide
N,N-Dimethylformamide concentrations have more than halved since 2017.
Equity context · ACS 2018-2022 block-group demographics
Who Lives Next To This Facility
Within 3 miles of this facility (10 Census block groups, population-weighted demographics): a population of 11,720. Why we surface this →
57.4%
Low-income
59.8%
People of color
9.9%
Under age 5
11.4%
Over age 64
Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.
Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.
What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.